MycoBiomDB – Record Details (MyCo_6700)

Biomarker Record Details

Database ID: MyCo_6700
DB IDMyCo_6700
TitleDevelopment of SERS-based immunoassay for the detection of cryptococcosis biomarker
Year2022
PMID35441260
Fungal Diseases involvedCryptococcosis
Associated Medical ConditionNone
GenusCryptococcus
Speciesspp.
OrganismCryptococcus spp.
Ethical StatementNone
Site of InfectionNone
Opportunistic invasiveOpportunistic
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameGXM
Biomarker Full NameGlucuronoxylomannan
Biomarker TypeDiagnostic
BiomoleculeMetabolite
Geographical LocationChina
CohortNone
Cohort No.None
Age GroupNone
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismCryptococcosis is one of the most common opportunistic systemic fungal infections among human immune-deficiency virus/acquired immune-deficiency syndrome (HIV/AIDS) patients and other immune-suppressed individuals resulted from cancer chemotherapy, diabetes mellitus, steroid therapy, renal transplantation, etc.. Nonetheless, up to 20% of cases occur in phenotypically “normal” or clinically immunocompetent patients. The most common etiological agents of cryptococcosis is Cryptococcus neoformans (C. neoformans), which is ubiquitously found in soil and the feces of birds. Upon inhalation of infectious propagules, C. neoformans penetrate the lung tissue, causing pulmonary cryptococcosis, and possibility leading to the dissemination to other organs, most commonly the brain. Therefore, the early clinical diagnosis of cryptococcosis infection is very essential in improving the curative and survival rates.
TechniqueELISA
Analysis MethodSurface-enhanced Raman scattering (SERS) - ELISA Based
ELISA kitsNone
Assay DataNone
Validation Techniques usedELISA, Transmission electron microscopy (TEM),
Up Regulation Down RegulationNone
Sequence DataNone
External LinkNone